Serina Therapeutics Inc (SER)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,898 | -19,215 | -15,879 | -11,284 | -4,822 |
| Depreciation Amortization | 82 | 131 | 49 | 33 | 17 |
| Accounts payable and accrued liabilities | 896 | 1,197 | 2,008 | 963 | 441 |
| Other Working Capital | 508 | 1,470 | 2,557 | 1,161 | 455 |
| Other Operating Activity | 844 | -1,538 | -657 | 1,055 | -413 |
| Operating Cash Flow | $-4,568 | $-17,955 | $-11,922 | $-8,072 | $-4,322 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -25 | -59 | -59 | -46 | N/A |
| Investing Cash Flow | $-25 | $-59 | $-59 | $-46 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 4,913 | 4,913 | N/A | N/A |
| Common Stock Issued | 26,057 | 7,559 | 7,078 | 5,547 | 4,917 |
| Other Financing Activity | 0 | 4,940 | 4,940 | 4,940 | 0 |
| Financing Cash Flow | $26,057 | $17,412 | $16,931 | $10,487 | $4,917 |
| Exchange Rate Effect | 6 | -14 | -2 | N/A | N/A |
| Beginning Cash Position | 3,056 | 3,672 | 3,672 | 3,672 | 3,672 |
| End Cash Position | 24,526 | 3,056 | 8,620 | 6,041 | 4,267 |
| Net Cash Flow | $21,470 | $-616 | $4,948 | $2,369 | $595 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,568 | -17,955 | -11,922 | -8,072 | -4,322 |
| Capital Expenditure | -25 | -59 | -59 | -46 | N/A |
| Free Cash Flow | -4,593 | -18,014 | -11,981 | -8,118 | -4,322 |